Variant report

Variant	nsv1043766
Chromosome Location	chr13:66156760-66200462
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 726 )
Associated
traits (count: 101 )

Variant overlapped rSNPs/rCNVs (count:726 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs188514769	chr13:66156767-66156768	Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs187002543	chr13:66156835-66156836	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs533121605	chr13:66156865-66156866	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs115466871	chr13:66156867-66156868	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs146546588	chr13:66156894-66156895	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs529552622	chr13:66156914-66156915	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs145735501	chr13:66156937-66156938	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs148930737	chr13:66156963-66156964	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs79949910	chr13:66156965-66156966	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs563664240	chr13:66156998-66156999	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs547143543	chr13:66157020-66157021	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs181354490	chr13:66157045-66157046	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs547714151	chr13:66157071-66157072	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs185999540	chr13:66157072-66157073	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs114482038	chr13:66157096-66157097	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs141676984	chr13:66157107-66157108	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs556208414	chr13:66157114-66157115	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs550210589	chr13:66157121-66157122	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs112292088	chr13:66157155-66157156	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs143636909	chr13:66157216-66157217	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs373439795	chr13:66157258-66157259	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs555660727	chr13:66157276-66157277	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs536274640	chr13:66157290-66157291	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs374227958	chr13:66157358-66157359	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs572129838	chr13:66157380-66157381	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs76473473	chr13:66157388-66157389	Enhancers Weak transcription Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
27	rs557941485	chr13:66157443-66157444	Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs577719050	chr13:66157487-66157488	Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs572163358	chr13:66157491-66157492	Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs543370824	chr13:66157532-66157533	Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs563340038	chr13:66157576-66157577	Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs79515761	chr13:66157602-66157603	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs182262320	chr13:66157604-66157605	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
34	rs560011542	chr13:66157643-66157644	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs113020856	chr13:66157645-66157646	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs528651590	chr13:66157650-66157651	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs551955274	chr13:66157652-66157653	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
38	rs187309255	chr13:66157655-66157656	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs549947167	chr13:66157723-66157724	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs190464489	chr13:66157735-66157736	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
41	rs535466131	chr13:66157797-66157798	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs182995748	chr13:66157919-66157920	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs7139932	chr13:66157970-66157971	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs9571435	chr13:66157973-66157974	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs534471464	chr13:66158006-66158007	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs148278172	chr13:66158036-66158037	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs533964397	chr13:66158037-66158038	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs577455601	chr13:66158041-66158042	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs537126713	chr13:66158109-66158110	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs186268035	chr13:66158138-66158139	Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:101)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Autism	22495311	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Squamous cell cancer	20885788	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Thyroid cancer	19087340	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	17133270	CNVD
Myoepithelioma	18604193	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Prostate cancer	16573809	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Prostate cancer	17245344	CNVD
Prostate cancer	18632612	CNVD
Colorectal cancer	21586687	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Retinoblastoma	19183342	CNVD
Developmental delay	21147756	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Merkel cell carcinoma	19020549	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
lymphocytic leukemia	21291569	CNVD
Breast cancer	21858162	CNVD
Glioblastoma multiforme	21922591	CNVD
Metanephric adenoma	20802469	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Gastric cancer	17908304	CNVD
Glioblastoma multiforme	21750150	CNVD
Breast cancer	17603634	CNVD
Cancer	21183584	CNVD
Breast cancer	17393978	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Liposarcoma	21253554	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Colorectal cancer	16774939	CNVD
Adenoid cystic carcinoma	17372589	CNVD
abnormal development	18461090	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Prostate cancer	16461572	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Intellectual disability	21811512	CNVD
Colorectal cancer	21645411	CNVD
Melanoma	20877625	CNVD
T-cell lymphomas	22341440	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Bipolar disorder	19114987	CNVD

Chromatin state (count:124 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:66155800-66158800	Enhancers	iPS-18 Cell Line	embryonic stem cell
2	chr13:66156000-66156800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
3	chr13:66156000-66156800	Enhancers	H9 Cell Line	embryonic stem cell
4	chr13:66156000-66156800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr13:66156000-66157400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr13:66156000-66158800	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
7	chr13:66156200-66156800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
8	chr13:66156400-66157400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
9	chr13:66156600-66156800	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
10	chr13:66156600-66156800	Enhancers	iPS-20b Cell Line	embryonic stem cell
11	chr13:66156600-66157400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
12	chr13:66156800-66157200	Enhancers	HUES6 Cell Line	embryonic stem cell
13	chr13:66156800-66158000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
14	chr13:66156800-66158400	Weak transcription	H9 Cell Line	embryonic stem cell
15	chr13:66157200-66158800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
16	chr13:66157400-66157600	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
17	chr13:66157400-66158200	Flanking Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
18	chr13:66157400-66158400	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
19	chr13:66157600-66158200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
20	chr13:66158000-66158200	Enhancers	iPS-20b Cell Line	embryonic stem cell
21	chr13:66158200-66158400	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
22	chr13:66158200-66158400	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
23	chr13:66158200-66158600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
24	chr13:66158200-66158800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr13:66158400-66158600	Enhancers	H9 Cell Line	embryonic stem cell
26	chr13:66158600-66158800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
27	chr13:66158600-66158800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
28	chr13:66159200-66159800	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
29	chr13:66159400-66159600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
30	chr13:66159400-66159600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
31	chr13:66159400-66159600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
32	chr13:66159400-66160000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr13:66159600-66159800	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
34	chr13:66159600-66159800	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
35	chr13:66159600-66159800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
36	chr13:66159800-66160200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
37	chr13:66166800-66167800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
38	chr13:66166800-66169200	Enhancers	Fetal Lung	lung
39	chr13:66166800-66171200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
40	chr13:66167000-66167200	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
41	chr13:66167000-66167400	Enhancers	Cortex derived primary cultured neurospheres	brain
42	chr13:66167000-66167400	Enhancers	Fetal Heart	heart
43	chr13:66167000-66167400	Enhancers	Fetal Stomach	stomach
44	chr13:66167000-66167600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
45	chr13:66167000-66169200	Enhancers	Fetal Adrenal Gland	Adrenal Gland
46	chr13:66167000-66169400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
47	chr13:66167000-66169400	Enhancers	NH-A	brain
48	chr13:66167400-66167600	Weak transcription	Cortex derived primary cultured neurospheres	brain
49	chr13:66167400-66167600	Weak transcription	Fetal Stomach	stomach
50	chr13:66167400-66167800	Weak transcription	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links